top of page
Expansion Rx News:
Site Under Construction
Mar 2, 2023
Expansion Therapeutics Announces Key Additions and Updates to Scientific Advisory Board
Expansion Therapeutics Announces Key Additions and Updates to Scientific Advisory Board
2,436
Oct 26, 2022
Expansion Therapeutics Appoints Raymond Kelleher, M.D., Ph.D., to its Board of Directors
Expansion Therapeutics Appoints Raymond Kelleher, M.D., Ph.D., to its Board of Directors
1,182
Jan 24, 2022
Expansion Therapeutics Names Sudhir Rao Senior Vice President of Business Development
-- Recognized industry leader brings deep scientific and operational experience to Expansion board. Boston, January 24, 2022 --...
951
Jan 19, 2022
Expansion Therapeutics Appoints Gary Bridger, Ph.D., to its Board of Directors
-- Recognized industry leader brings deep scientific and operational experience to Expansion board. Boston, January 19, 2022 -- Expansion...
553
Sep 29, 2021
Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases
-- Funding to advance the company’s SMiRNA™ platform to identify clinical candidates in myotonic dystrophy type 1 (DM1), amyotrophic...
4,808
Jun 14, 2021
Expansion Therapeutics Names Mark Ledeboer, Ph.D., Senior Vice President of Drug Discovery
Mark Ledeboer, Ph.D., Senior Vice President of Drug Discovery
465
May 24, 2021
Expansion Therapeutics Announces In-Licensing of Two New Research Programs from Scripps Research...
Expansion Therapeutics Announces In-Licensing of Two New Research Programs from Scripps Research
818
May 5, 2021
Expansion Therapeutics Names Valerie Cullen, Ph.D., Senior Vice President of Research
Expansion Therapeutics Names Valerie Cullen, Ph.D., Senior Vice President of Research
461
Oct 4, 2020
Expansion Therapeutics Names Renato Skerlj, Ph.D., Chief Executive Officer and President
Meet Expansion Therapeutics New CEO
537
bottom of page